期刊文献+

ANCA与SLE临床表现的相关性及其意义 被引量:2

Anti-neutrophil Cytoplasmic Antibodies in Systemic Lupus Erythematosus
原文传递
导出
摘要 目的:探讨系统性红斑狼疮(Systemic Lupus Erythematosus,SLE)患者抗中性粒细胞胞浆抗体(Anti-neutrophil Cytoplasmic Antibodies,ANCA)与肾炎及其他临床表现和实验室检查的相关性及其意义。方法:采用前瞻性研究收集77例系统性红斑狼疮患者,用间接免疫荧光法(IIF)检测患者血清ANCA、ELISA法检测ANCA抗原,检测其他免疫学指标如抗核抗体、抗dsDNA抗体等。结果:77例SLE患者中ANCA阳性28(36.4%)例,ANCA阳性组浆膜炎、肾损害、神经精神症状、皮肤血管炎、抗dsDNA抗体阳性、抗Sm抗体阳性、补体下降以及血清IgG升高的发生率明显高于阴性组(P<0.05)。52例LN患者中,25例(48.1%)ANCA阳性,其中P-ANCA阳性者22例(88%),3例(12%)为a-ANCA均出现在RPGN,无一例出现c-ANCA。非LN组25例患者中,仅3例(12%)p-ANCA阳性,且均为抗-MPO。正常对照组无一例ANCA阳性。77例SLE患者中,14例(18.2%)为抗-MPO;13例(16.9%)为抗LF,且只见于DPGN、FPGN和RPGN伴有新月体形成者;10例(13%)为抗-CG,但在非狼疮肾炎患者未检测到抗-LF及抗-CG。在各种临床表现中,抗-MPO与肾脏和皮肤表现有关;而抗-LF与肾脏、关节炎及浆膜炎有关;抗-CG可见于各种临床表现。结论:ANCA可作为评价SLE疾病及鉴别血管炎和狼疮肾炎的一个重要指标。 Objective: To investigate the prevalence of ANCA in patients with Systemic Lupus Erythematosus(SLE) to find the association between ANCA and renal lesion and other clinical manifestations. Methods: The prospective study of 77 patients with SLE was used. Indirect immunofluorescenee (IIF) and ELISA were used to detect the ANCA and its target antigen. Results: 28 cases of 77 patients with SLE were ANCA positive. There are significant differences in the clinical features including serositis, nephropathy, neural disorder, cutaneous vasculitis as well as in laboratory results including Anti-dsDNA,Anti-Sm,higher serum IgG and lower levels of C3/C4 between SLE with ANCA positive group and negative group. In 52 patients with LN, 25(48.1%) was ANCA positive; between them, 22(88 %) were p-ANCA positive, and 3(12 %) were a-ANCA positive and all were RPGN, none was c-ANCA positive. 3(12 %) of 25 non-LN were ANCA positive and all were anti-MPO. There was no ANCA positive in normal control. Among 77 cases with SLE, there were 14cases(18.2 %) were anti-myeloperoxidase(anti-MPO); 13 cases(16.9 %) were anti-lactoferrin (anti-LF) and seen only in DPGN、FPGN and RPGN with crescents; 10 cases(13 %) were anti-cathepsin G(anti-CG). Anti-LF and anti-CG were not detected in non-LN patients. It was observed that anti-MPO was associated with renal and skin manifestation, while anti-LF was seen in renal and joint involvement and serositis. Patients having only anit-CG had a varied clinical presentation. Conclusion: ANCA in SLE may be used as a serological marker along with clinical and histopathological assessment to differentiate vasculitides in LN cases from SLE without nephritis.
出处 《现代生物医学进展》 CAS 2009年第11期2112-2114,共3页 Progress in Modern Biomedicine
基金 国家自然科学基金(30571684)
关键词 系统性红斑狼疮 狼疮肾炎 抗中性粒细胞胞浆抗体 Systemic Lupus Erythematosus lupus nephritis anti-neutrophil Cytoplasmic Antibodies
  • 相关文献

参考文献8

  • 1Pan HF, Fang XH, Wu GC, et al. Anti-neutrophil cytoplasmic antibodies in new-onset systemic lupus erythematosus and lupus nephritis[J]. Inflammation, 2008,31 (4):260-265
  • 2Fauzi AR, Kong NC, Chua MK, et al. Antibodies in systemic lupus antineutrophil cytoplasmic erythematosus: prevalence, disease activity correlations and organ system associations [J]. Med J Malaysia, 2004,59(3):372-377
  • 3Savige J, Neeson P, Trevisin M, et al. ELISA is the superior method for detecting antineutrophil cytoplasmic antibodies in the diagnosis of systemic necrotising vasculitis[J]. J Clin Pathol, 2000,53(8):644-645
  • 4Xin G, Zhao MH, Wang HY.Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in chinese patients with clinically suspected vasculitis [J]. Clin Diagn Lab Immunol, 2004, 11(3): 559-562
  • 5Khanna UB, Bhivandkar MG, Almeida AF, et al. Spectrum of renal involvement in SLE[J]. J Assoc Physicians India, 1987,35(9):623-626
  • 6尹志华,叶志中,罗秀霞,曾惠琼,张丽君.Survivin基因在系统性红斑狼疮患者中的异常表达[J].现代生物医学进展,2007,7(7):1033-1034. 被引量:6
  • 7Manolova I, Dancheva M, Halacheva K.Antineutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus: prevalence, antigen specificity, and clinical associations [J]. Rheumatol Int, 2001,20(5): 197-204
  • 8Nishiya K, Chikazawa H, Nishimura S, ct al. Anti-ncutrophil cytoplasmic antibody in patients with systemic lupus erythematosus is unrelated to clinical features[J]. Clin Rheumatol, 1997, 16(1):70-75

二级参考文献11

  • 1杨珂珂,李志军,陈琳洁,郭冉,黄厚章.系统性红斑狼疮合并消化道损害32例临床分析[J].现代生物医学进展,2006,6(11):65-66. 被引量:2
  • 2杨珂珂,李志军,陈琳洁,黄厚章.系统性红斑狼疮伴发急腹症的诊治思考-附18例临床分析[J].现代生物医学进展,2006,6(12):86-87. 被引量:3
  • 3ZANDMAN-GODDARD G,SHOENFELD Y.Infections and SLE[J].Autoimmunity,2005,38(7):473-485.
  • 4KYTTARIS VC,KRISHNAN S,TSOKOS GC.Systems biology in systemic lupus erythematosus:integrating genes,biology and immune function[J].Autoimmunity,2006,39(8):705-709.
  • 5HUGHES P,BOUILLET P,STRASSER A.Role of Bim and other Bcl-2 family members in autoimmune and degenerative diseases[J].Curr Dir Autoimmun,2006,9:74-94.
  • 6XUE C,LAN-LAN W,BEI C,et al.Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus[J].Cell Immunol,2006,239(2):121-128.
  • 7MIRET C,MOLINA R,FILELLA X,et al.Relationship of p53 with other oncogenes,cytokines and systemic lupus erythematosus activity[J].Tumour Biol,2003,24(4):185-188.
  • 8KUROSAKA D,YASUDA J,YOSHTOA K,et al.Telomerase activity and telomere length of peripheral blood mononuclear cells in SLE patients[J].Lupus,2003,12(8):591-599.
  • 9KLAPPER W,MOOSIG F,SOTNIKOVA A,et al.Telomerase activity in B and T lymphocytes of patients with systemic lupus erythematosus[J].Ann Rheum Dis.2004,63(12):1681-1683.
  • 10ALTIERI DC.The case for survivin as a regulator of microtubule dynamics and cell-death decisions[J].Curr Opin Cell Biol,2006,18(6):609-615.

共引文献5

同被引文献21

  • 1李晓,陈晓农,任红,张文,陈楠.狼疮性肾炎患者血脂异常的临床意义[J].中国微循环,2006,10(3):202-204. 被引量:3
  • 2Franssen CFM, Stegen CA, Kallenberg CGM, et al. Antiproteinase 3 and antimyeloperoxidase associated vasculitis[J]. Kid Intern, 2000,57: 2195-2206.
  • 3Hochberb MC. Updaling the American College of Rheumatology revised criteria for the classification of systemic lupusrythematosus [J]. Arthritis Rheum, 1997,40(6): 1725.
  • 4Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI: a disease activity index for lupus patients [J]. Arthritis- Rheum, 1992, 35(6): 630-640.
  • 5Molnar K, Kovacs L, Kiss M, et al. Anti-neutrophil cytoplasmic anti- bodies in patients with systemic lupus erythematosus [J]. Clin Exp Dermatol, 2002,27( 1 ) :56-61.
  • 6Schnable A, Csemo KE, Isenberg DA, et al. Antineutrophil cytoplas- mic antibodies in systemic lupus erythematosus; Prevalence's peci- ficifies, and clinical significance [J]. Arthritis Rheum, 1995,38: 633-637.
  • 7张琳,张伟.系统性红斑狼疮相关的生物标志物[J].中国免疫学杂志,2007,23(9):860-863. 被引量:19
  • 8Spoerl D, Per YM, Jorgensen C. Anti-neutrophil cytoplasmic antibodies in rheumatoid arthritis: two case reports and review of literature[J]. Allergy Asthma Clin Immunol, 2012, 8( 1 ) : 19.
  • 9Qiuyu L, Di S, Wang FM, et al. Clinicopathological charac- teristics and outcomes of chinese patients with scanty immune deposits lupus nephritis: a large cohort study from a single center[J]. Sci World J, 2014, 2014(2): 1-11.
  • 10郭永辉,段丽,孙静涛.VEGF和内皮抑素表达在高血压病合并颈动脉粥样硬化中的作用[J].中国误诊学杂志,2009,9(17):4051-4051. 被引量:2

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部